GO:0000295 adenine nucleotide transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000295 describes the molecular function that enables the transfer of AMP, ADP, and ATP across biological membranes.
• The mitochondrial ADP/ATP carrier (SLC25A4/SLC25A5/SLC25A6) is the best-characterized protein family performing this function, using a single-binding-center alternating-access mechanism.
• Adenine nucleotide transport is essential for cellular energy homeostasis, linking mitochondrial ATP production to cytosolic energy-consuming processes.
• Defects in adenine nucleotide transporters are linked to mitochondrial myopathies, cardiomyopathies, and metabolic disorders.
• The Na,K-ATPase and CFTR are not adenine nucleotide transporters themselves but depend on adenine nucleotide binding and transport for their function.
• CRISPR knockout, point-mutation, and knock-in models are powerful tools to dissect the physiological roles of adenine nucleotide transporter genes.
Description
Adenine nucleotide transmembrane transporter activity (GO:0000295) is a molecular function that enables the movement of AMP, ADP, and ATP across biological membranes. This activity is fundamental to cellular energy metabolism because ATP is synthesized primarily in the mitochondrial matrix but is consumed in the cytosol and other compartments. The mitochondrial ADP/ATP carrier (AAC), also known as the adenine nucleotide translocase (ANT), is the prototypical protein that performs this function, exchanging cytosolic ADP for mitochondrial ATP. Researchers study GO:0000295 to understand how cells balance energy production and consumption, and how defects in this process contribute to human disease. Beyond mitochondria, adenine nucleotide transport also occurs in other cellular contexts, such as the Golgi apparatus and the plasma membrane, where it supports glycosylation, signaling, and ion transport. This article provides a research-grade overview of the genes, mechanisms, and experimental models relevant to GO:0000295.
adenine nucleotide transmembrane transporter activity At A Glance
| GO ID | GO:0000295 |
|---|---|
| GO term | adenine nucleotide transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Transfer of AMP, ADP, and ATP across membranes |
| Representative proteins | SLC25A4 (ANT1), SLC25A5 (ANT2), SLC25A6 (ANT3), SLC25A31 (ANT4) |
| Cellular locations | Inner mitochondrial membrane, Golgi membrane, plasma membrane |
| Associated processes | Oxidative phosphorylation, energy homeostasis, mitochondrial transport |
| Disease relevance | Mitochondrial myopathies, cardiomyopathies, metabolic syndromes |
What Is GO:0000295?
In simple terms, GO:0000295 is the activity that moves adenine nucleotides (AMP, ADP, and ATP) from one side of a membrane to the other. According to the QuickGO definition, it enables the transfer of these molecules across a lipid bilayer, typically through a protein transporter embedded in the membrane. This function is distinct from ATP synthesis or hydrolysis; it specifically describes the translocation step. The activity is essential for shuttling energy carriers between cellular compartments, most notably between mitochondria and the cytosol.
Why Is adenine nucleotide transmembrane transporter activity Important in Cell Biology?
Adenine nucleotide transmembrane transporter activity is central to life because it connects the site of ATP production with the sites of ATP consumption. Without efficient exchange of ADP and ATP across the inner mitochondrial membrane, oxidative phosphorylation would stall, and cells would be unable to meet their energy demands. This function also supports specialized processes such as Golgi glycosylation, where nucleotide sugars and nucleotides must be transported, and cardiac function, where nucleotide transport is critical for myocardial contractility. Understanding GO:0000295 is therefore essential for researchers studying metabolism, mitochondrial biology, and a wide range of diseases.
• Maintains cellular energy homeostasis by balancing ATP/ADP ratios across compartments.
• Enables oxidative phosphorylation by importing ADP into mitochondria and exporting ATP.
• Supports cardiac function, as myocardial nucleotide transport is essential for contraction.
• Contributes to Golgi apparatus function by transporting nucleotide derivatives.
• Is implicated in mitochondrial myopathies and cardiomyopathies when defective.
• Provides a target for understanding metabolic reprogramming in cancer.
• Helps explain the action of drugs that target mitochondrial transporters.
• Links to ion transport mechanisms such as Na,K-ATPase and CFTR via nucleotide binding.
• Serves as a model for studying membrane protein structure and transport mechanisms.
• Offers opportunities for CRISPR-based disease modeling and therapeutic development.
What Happens During adenine nucleotide transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter grabs the nucleotide it needs to move.
The mitochondrial ADP/ATP carrier (AAC) binds ADP or ATP with high specificity through a single binding center located in the central cavity of the protein. This binding is competitive, and the carrier alternates between a cytoplasmic-open and a matrix-open state. The binding site recognizes the adenine ring and the phosphate groups, ensuring that only adenine nucleotides are transported.
Conformational transition and translocation
In simple terms: The transporter changes shape to push the nucleotide across the membrane.
Upon binding, the AAC undergoes a conformational change from the cytoplasmic-open to the matrix-open state, a process described by the alternating-access mechanism. This transition involves the movement of three homologous repeats within the protein, creating a pathway for the nucleotide to cross the inner mitochondrial membrane. The carrier then releases the nucleotide on the opposite side and returns to its original state.
Exchange and energy coupling
In simple terms: The transporter swaps one nucleotide for another to keep energy flowing.
The AAC functions as an exchanger, typically exchanging cytosolic ADP for mitochondrial ATP. This exchange is driven by the electrochemical gradient across the inner mitochondrial membrane and is essential for maintaining the ATP/ADP ratio in the cytosol. The transport is electrogenic, as ADP and ATP carry different charges, and the process is tightly coupled to the proton motive force.
Regulation by nucleotides and membrane potential
In simple terms: The transporter's activity is tuned by the cell's energy state.
Adenine nucleotide transport is regulated by the concentrations of ADP and ATP, as well as by the mitochondrial membrane potential. High cytosolic ADP levels stimulate transport, while high ATP levels inhibit it, providing feedback control. Additionally, post-translational modifications and interactions with other proteins, such as the permeability transition pore, can modulate AAC activity.
Key Genes Involved in GO:0000295 adenine nucleotide transmembrane transporter activity
The following genes encode proteins that exhibit adenine nucleotide transmembrane transporter activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A4 (ANT1) | Mitochondrial ADP/ATP carrier; heart and skeletal muscle isoform | Mutations cause mitochondrial myopathy and cardiomyopathy |
| SLC25A5 (ANT2) | Mitochondrial ADP/ATP carrier; widely expressed isoform | Upregulated in proliferating cells and cancer |
| SLC25A6 (ANT3) | Mitochondrial ADP/ATP carrier; housekeeping isoform | Involved in basal energy metabolism |
| SLC25A31 (ANT4) | Mitochondrial ADP/ATP carrier; testis-specific isoform | Essential for spermatogenesis |
| SLC25A51 | Mitochondrial NAD+ transporter | Related to NAD+ transport, not adenine nucleotides, but studied in AML |
| ATP1A1 | Na,K-ATPase alpha subunit | Binds ATP and couples ion transport to ATP hydrolysis |
| CFTR | ABC transporter chloride channel | Nucleotide-binding domains catalyze adenylate kinase activity |
| SPCA2 | Secretory pathway Ca2+-ATPase | Regulates CFTR activity via STIM1-ORAI1 |
| SLC33A1 | Golgi acetyl-CoA transporter | Involved in Golgi sialic acid O-acetylation, not adenine nucleotide transport |
| CASD1 | Golgi sialic acid O-acetyltransferase | Interacts with SLC33A1 in Golgi function |
| VDAC1 | Voltage-dependent anion channel | Allows nucleotide passage across outer mitochondrial membrane |
| VDAC2 | Voltage-dependent anion channel | Isoform with distinct nucleotide permeability |
| VDAC3 | Voltage-dependent anion channel | Less characterized isoform |
| ANT1 (SLC25A4) variants | Pathogenic mutations | Modeled in CRISPR knock-in studies |
| ANT2 (SLC25A5) variants | Cancer-associated overexpression | Target for CRISPR knockout in cancer models |
| ANT3 (SLC25A6) variants | Housekeeping function | Used in knockout studies for basal metabolism |
| ANT4 (SLC25A31) variants | Testis-specific function | Knockout models reveal fertility defects |
How Is adenine nucleotide transmembrane transporter activity Regulated?
Adenine nucleotide transmembrane transporter activity is regulated at multiple levels. The mitochondrial ADP/ATP carrier is controlled by the cellular energy charge, with ADP and ATP concentrations directly influencing its exchange rate. The mitochondrial membrane potential and the proton motive force also modulate transport activity. In addition, post-translational modifications such as phosphorylation and acetylation can affect carrier function. In the Golgi apparatus, SLC33A1-dependent transport of acetyl-CoA, though not an adenine nucleotide transporter itself, indirectly influences nucleotide sugar transport and glycosylation. In the heart, myocardial nucleotide transport is regulated by oxygen availability and workload, ensuring that ATP supply matches demand. These regulatory mechanisms allow cells to adapt to changing metabolic conditions.
adenine nucleotide transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A4 (ANT1) | Mitochondrial myopathy, cardiomyopathy | CRISPR knockout in mouse skeletal muscle |
| SLC25A5 (ANT2) | Cancer proliferation, metabolic reprogramming | CRISPR knockout in cancer cell lines |
| SLC25A6 (ANT3) | Basal energy metabolism defects | CRISPR knockout in HEK293 cells |
| SLC25A31 (ANT4) | Male infertility | CRISPR knockout in mouse testis |
| SLC25A51 | Acute myeloid leukemia | CRISPR knockout in AML cell lines |
Mitochondrial myopathies and cardiomyopathies
Mutations in SLC25A4 (ANT1) cause mitochondrial myopathy and cardiomyopathy, characterized by muscle weakness and cardiac dysfunction. These mutations impair ADP/ATP exchange, leading to energy deficiency in highly oxidative tissues. CRISPR knockout models of SLC25A4 in mice recapitulate these phenotypes, providing insights into disease mechanisms.
Cancer metabolism
SLC25A5 (ANT2) is often overexpressed in cancer cells, where it supports the high energy demand of proliferation. Targeting ANT2 with CRISPR knockout reduces tumor growth in preclinical models, suggesting a potential therapeutic strategy. Additionally, SLC25A51, a mitochondrial NAD+ transporter, is being studied in acute myeloid leukemia, highlighting the broader importance of mitochondrial transport in cancer.
Cardiac dysfunction
Myocardial nucleotide transport is critical for cardiac contractility, and its impairment contributes to heart failure. Studies in animal models show that altered adenine nucleotide transport leads to reduced ATP supply and contractile dysfunction. This makes the adenine nucleotide transporter a potential target for cardioprotective therapies.
Golgi-related disorders
Although not directly an adenine nucleotide transporter, SLC33A1-dependent Golgi function affects glycosylation and is linked to spastic paraplegia and other disorders. Defects in Golgi nucleotide transport can disrupt protein glycosylation and secretion.
From adenine nucleotide transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC25A4 impair mitochondrial ATP export? | CRISPR knockout in HeLa or HEK293 cells |
| Can a patient mutation in SLC25A4 be corrected? | CRISPR knock-in of wild-type allele in patient fibroblasts |
| What is the effect of ANT2 overexpression on cancer growth? | CRISPR overexpression in cancer cell lines |
| Does a point mutation in the ADP/ATP carrier alter substrate specificity? | CRISPR point mutation in SLC25A5 |
| How does ANT4 knockout affect spermatogenesis? | CRISPR knockout in mouse models |
| Can tagged ANT1 be used to study its localization? | CRISPR knock-in of fluorescent tag in SLC25A4 |
How to Study the adenine nucleotide transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive transport assay | ADP/ATP exchange rate | Kinetic analysis of purified ANT |
| Cryo-EM | Protein structure in different states | Mechanistic studies of ANT |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Identifying regulators of energy metabolism |
| Seahorse assay | Oxygen consumption rate and extracellular acidification | Mitochondrial function in knockout cells |
| 13C flux analysis | Metabolic pathway activity | Quantifying ATP production |
| Western blot | Protein expression levels | Validating CRISPR knockouts |
| Immunofluorescence | Protein localization | Studying ANT isoforms in cells |
| Patch clamp | Ion channel activity | Studying CFTR and Na,K-ATPase |
Transport assays
Transport activity of adenine nucleotide transporters can be measured using isolated mitochondria or proteoliposomes reconstituted with purified protein. Radioactive ADP or ATP flux assays are commonly used to quantify exchange rates. These assays are essential for determining kinetic parameters and substrate specificity.
Structural biology
X-ray crystallography and cryo-electron microscopy have revealed the structure of the mitochondrial ADP/ATP carrier in different conformations. These structures provide a framework for understanding the alternating-access mechanism and for designing mutations that alter function. Similar approaches are used for ABC transporters, which share nucleotide-binding domains.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that modulate adenine nucleotide transport and cellular energy metabolism. Such screens have been used to find synthetic lethal interactions with mitochondrial transporters in cancer. These methods are powerful for discovering new regulators of GO:0000295.
Metabolic flux analysis
Seahorse extracellular flux analysis and 13C metabolic flux analysis measure mitochondrial respiration and ATP production in live cells. These techniques can assess the impact of manipulating adenine nucleotide transporter genes on cellular bioenergetics. They are widely used in studies of mitochondrial myopathies and cancer metabolism.
How CRISPR Can Be Used to Study GO:0000295 adenine nucleotide transmembrane transporter activity
Knockout
CRISPR knockout of SLC25A4, SLC25A5, or SLC25A6 in cell lines abolishes specific ADP/ATP carrier isoforms, allowing researchers to study their individual contributions to mitochondrial function. Knockout mice for Slc25a4 develop mitochondrial myopathy, demonstrating the physiological importance of this transporter. These models are valuable for testing compensatory mechanisms among isoforms.
Point Mutation
CRISPR point mutation can introduce disease-associated mutations into endogenous SLC25A4 or SLC25A5 genes, such as the A114P mutation linked to cardiomyopathy. These models help dissect how specific amino acid changes affect substrate binding and transport kinetics. Point mutations in the nucleotide-binding domains of CFTR have also been studied using CRISPR to understand adenylate kinase activity.
Knock-in
CRISPR knock-in can insert tags, such as FLAG or GFP, into endogenous adenine nucleotide transporter genes to study protein localization and interactions. Knock-in of wild-type alleles can rescue phenotypes in patient-derived cells, providing proof of causality. This approach is also used to create reporter cell lines for high-throughput screening.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase the levels of SLC25A5 (ANT2) to study its role in cancer cell proliferation. Overexpression of ANT isoforms in yeast or mammalian cells has been used to characterize their transport properties. These models are useful for identifying downstream metabolic changes.
How EDITGENE Supports adenine nucleotide transmembrane transporter activity Research
Researchers studying adenine nucleotide transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies of GO:0000295 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for adenine nucleotide transmembrane transporter activity research.
Frequently Asked Questions About adenine nucleotide transmembrane transporter activity
What is adenine nucleotide transmembrane transporter activity?
It is a molecular function (GO:0000295) that enables the transfer of AMP, ADP, and ATP across biological membranes, typically through specialized carrier proteins.
What genes are involved in adenine nucleotide transmembrane transporter activity?
The main genes are SLC25A4 (ANT1), SLC25A5 (ANT2), SLC25A6 (ANT3), and SLC25A31 (ANT4), which encode mitochondrial ADP/ATP carriers.
How does the mitochondrial ADP/ATP carrier work?
It uses an alternating-access mechanism to exchange cytosolic ADP for mitochondrial ATP, driven by the membrane potential.
What diseases are associated with defects in adenine nucleotide transport?
Mutations in SLC25A4 cause mitochondrial myopathy and cardiomyopathy, while ANT2 overexpression is linked to cancer.
What is the role of adenine nucleotide transport in cancer?
Cancer cells often upregulate ANT2 to meet high energy demands, making it a potential therapeutic target.
How can CRISPR be used to study adenine nucleotide transporters?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of transporter genes to study their function and disease relevance.
What methods are used to measure adenine nucleotide transport activity?
Radioactive transport assays, Seahorse flux analysis, and structural biology techniques such as cryo-EM are commonly used.
Is the Na,K-ATPase an adenine nucleotide transporter?
No, the Na,K-ATPase is an ion pump that binds ATP but does not transport adenine nucleotides across membranes.
What is the difference between ANT and VDAC?
ANT is located in the inner mitochondrial membrane and exchanges ADP/ATP, while VDAC is in the outer membrane and allows nucleotide passage.
How does EDITGENE support research on adenine nucleotide transporters?
EDITGENE provides custom CRISPR knockout, point mutation, knock-in, overexpression, and library screening services for genes related to GO:0000295.
Conclusion
Adenine nucleotide transmembrane transporter activity (GO:0000295) is a fundamental molecular function that sustains cellular energy metabolism by moving AMP, ADP, and ATP across membranes. The mitochondrial ADP/ATP carriers are the best-studied examples, and their dysfunction is linked to severe metabolic and cardiac diseases. Advances in CRISPR-based genome editing now enable precise dissection of these transporters in physiologically relevant models, offering new opportunities for therapeutic development. Continued research into GO:0000295 will deepen our understanding of energy homeostasis and provide insights into diseases such as mitochondrial myopathies and cancer.
References
- 1. Rong C et al.. 2026. SLC25A51 and mitochondrial NAD⁺ transport in acute myeloid leukemia: mechanisms, therapeutic potential, and translational perspectives.. Hum Cell 39(8) PMID: 42472419
- 2. Kaplan JH. 2002. Biochemistry of Na,K-ATPase.. Annu Rev Biochem 71:511-35 PMID: 12045105
- 3. Gross CH et al.. 2006. Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.. J Biol Chem 281(7):4058-68 PMID: 16361259
- 4. Kiss AK et al.. 2025. Store-independent activation of STIM1-ORAI1 by SPCA2 determines the basal CFTR activity in secretory epithelial cells.. Curr Biol 35(20):4970-4987.e7 PMID: 41015040
- 5. Albers M et al.. 2026. Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis.. Nat Commun 17(1) PMID: 41917001
- 6. Kunji ER et al.. 2016. The transport mechanism of the mitochondrial ADP/ATP carrier.. Biochim Biophys Acta 1863(10):2379-93 PMID: 27001633
- 7. Zolnerciks JK et al.. 2011. Structure of ABC transporters.. Essays Biochem 50(1):43-61 PMID: 21967051
- 8. Rovetto MJ. 1985. Myocardial nucleotide transport.. Annu Rev Physiol 47:605-16 PMID: 2986540
